Vericel Corporation (VCEL)
USD 56.25
(-0.78%)
USD 56.25
(-0.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 88.14 Million USD | 85.29% |
| 2022 | 47.57 Million USD | -5.04% |
| 2021 | 50.09 Million USD | -5.8% |
| 2020 | 53.18 Million USD | 91.98% |
| 2019 | 27.7 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 17.23 Million USD | 70.18% |
| 2016 | 10.12 Million USD | 14166.2% |
| 2015 | 71 Thousand USD | -34.86% |
| 2014 | 109 Thousand USD | 1716.67% |
| 2013 | 6000.00 USD | -85.0% |
| 2012 | 40 Thousand USD | -50.0% |
| 2011 | 80 Thousand USD | -68.63% |
| 2010 | 255 Thousand USD | -67.47% |
| 2009 | 784 Thousand USD | -36.21% |
| 2008 | 1.22 Million USD | -19.99% |
| 2007 | 1.53 Million USD | 0.0% |
| 2006 | 1.53 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | -100.0% |
| 1998 | 65 Thousand USD | -67.5% |
| 1997 | 200 Thousand USD | -99.42% |
| 1996 | 34.6 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 92.3 Million USD | 4.72% |
| 2024 Q2 | 95.79 Million USD | 3.77% |
| 2023 Q2 | 83.36 Million USD | 77.89% |
| 2023 FY | 88.14 Million USD | 85.29% |
| 2023 Q1 | 46.86 Million USD | -1.49% |
| 2023 Q3 | 85.06 Million USD | 2.04% |
| 2023 Q4 | 88.14 Million USD | 3.62% |
| 2022 Q3 | 48.11 Million USD | -0.13% |
| 2022 Q1 | 49.26 Million USD | -1.67% |
| 2022 Q4 | 47.57 Million USD | -1.14% |
| 2022 FY | 47.57 Million USD | -5.04% |
| 2022 Q2 | 48.18 Million USD | -2.19% |
| 2021 Q4 | 50.09 Million USD | -1.49% |
| 2021 FY | 50.09 Million USD | -5.8% |
| 2021 Q3 | 50.85 Million USD | -1.52% |
| 2021 Q2 | 51.64 Million USD | -1.57% |
| 2021 Q1 | 52.46 Million USD | -1.35% |
| 2020 FY | 53.18 Million USD | 91.98% |
| 2020 Q1 | 27.13 Million USD | -2.06% |
| 2020 Q2 | 26.58 Million USD | -2.02% |
| 2020 Q4 | 53.18 Million USD | 91.97% |
| 2020 Q3 | 27.7 Million USD | 4.21% |
| 2019 Q3 | 28.14 Million USD | 3.61% |
| 2019 Q4 | 27.7 Million USD | -1.58% |
| 2019 FY | 27.7 Million USD | 0.0% |
| 2019 Q1 | 27.48 Million USD | 0.0% |
| 2019 Q2 | 27.16 Million USD | -1.16% |
| 2018 Q4 | - USD | -100.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q1 | 17.24 Million USD | 0.05% |
| 2018 Q2 | 17.26 Million USD | 0.1% |
| 2018 Q3 | 17.28 Million USD | 0.09% |
| 2017 Q2 | 10.16 Million USD | 0.17% |
| 2017 Q3 | 9.95 Million USD | -2.03% |
| 2017 Q1 | 10.14 Million USD | 0.17% |
| 2017 FY | 17.23 Million USD | 70.18% |
| 2017 Q4 | 17.23 Million USD | 73.12% |
| 2016 Q1 | 62 Thousand USD | -12.68% |
| 2016 Q4 | 10.12 Million USD | 80.62% |
| 2016 Q3 | 5.6 Million USD | 138.03% |
| 2016 Q2 | 2.35 Million USD | 3700.0% |
| 2016 FY | 10.12 Million USD | 14166.2% |
| 2015 FY | 71 Thousand USD | -34.86% |
| 2015 Q2 | 91 Thousand USD | -9.0% |
| 2015 Q3 | 81 Thousand USD | -10.99% |
| 2015 Q1 | 100 Thousand USD | 0.0% |
| 2015 Q4 | 71 Thousand USD | -12.35% |
| 2014 Q1 | 2000.00 USD | -66.67% |
| 2014 FY | 109 Thousand USD | 1716.67% |
| 2014 Q4 | 100 Thousand USD | -34.64% |
| 2014 Q3 | 153 Thousand USD | -93.88% |
| 2014 Q2 | 2.5 Million USD | 124900.0% |
| 2013 Q1 | 29 Thousand USD | -27.5% |
| 2013 FY | 6000.00 USD | -85.0% |
| 2013 Q2 | 19 Thousand USD | -34.48% |
| 2013 Q3 | 10 Thousand USD | -47.37% |
| 2013 Q4 | 6000.00 USD | -40.0% |
| 2012 FY | 40 Thousand USD | -50.0% |
| 2012 Q4 | 40 Thousand USD | -18.37% |
| 2012 Q3 | 49 Thousand USD | -16.95% |
| 2012 Q2 | 59 Thousand USD | -14.49% |
| 2012 Q1 | 69 Thousand USD | -13.75% |
| 2011 Q4 | 80 Thousand USD | -20.0% |
| 2011 Q1 | 202 Thousand USD | 0.0% |
| 2011 Q3 | 100 Thousand USD | -31.51% |
| 2011 Q2 | 146 Thousand USD | -27.72% |
| 2011 FY | 80 Thousand USD | -68.63% |
| 2010 Q1 | 428 Thousand USD | -21.9% |
| 2010 Q2 | 305 Thousand USD | -28.74% |
| 2010 Q3 | 280 Thousand USD | -8.2% |
| 2010 FY | 255 Thousand USD | -67.47% |
| 2009 Q2 | 784 Thousand USD | -12.69% |
| 2009 FY | 784 Thousand USD | -36.21% |
| 2009 Q4 | 548 Thousand USD | -17.84% |
| 2009 Q1 | 898 Thousand USD | -11.18% |
| 2009 Q3 | 667 Thousand USD | -14.92% |
| 2008 FY | 1.22 Million USD | -19.99% |
| 2008 Q1 | 1.33 Million USD | -7.35% |
| 2008 Q2 | 1.22 Million USD | -8.01% |
| 2008 Q3 | 1.12 Million USD | -8.79% |
| 2008 Q4 | 1.01 Million USD | -9.81% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | 1.47 Million USD | -3.71% |
| 2007 FY | 1.53 Million USD | 0.0% |
| 2007 Q4 | 1.44 Million USD | -2.5% |
| 2007 Q2 | 1.53 Million USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | 1.53 Million USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | -100.0% |
| 1999 FY | - USD | -100.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | 12 Thousand USD | -60.0% |
| 1998 FY | 65 Thousand USD | -67.5% |
| 1998 Q4 | 30 Thousand USD | -37.5% |
| 1998 Q3 | 48 Thousand USD | -26.15% |
| 1998 Q2 | 65 Thousand USD | -22.62% |
| 1998 Q1 | 84 Thousand USD | -16.83% |
| 1997 Q4 | 101 Thousand USD | -31.29% |
| 1997 FY | 200 Thousand USD | -99.42% |
| 1997 Q1 | 200 Thousand USD | -33.33% |
| 1997 Q2 | 200 Thousand USD | 0.0% |
| 1997 Q3 | 147 Thousand USD | -26.5% |
| 1996 Q4 | 300 Thousand USD | 0.0% |
| 1996 Q3 | 300 Thousand USD | 0.0% |
| 1996 FY | 34.6 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 61.582% |
| IO Biotech, Inc. | 2.49 Million USD | -3434.202% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -41088.318% |
| Organovo Holdings, Inc. | 1.39 Million USD | -6223.027% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -180262.185% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -53656.549% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -798.227% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1154.883% |
| Savara Inc. | 26.73 Million USD | -229.654% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -12958.222% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -251.981% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -322.055% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1018187.893% |
| Soligenix, Inc. | 3.49 Million USD | -2422.291% |
| Aptose Biosciences Inc. | 1 Million USD | -8628.706% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -342.463% |
| Century Therapeutics, Inc. | 48.17 Million USD | -82.979% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -110.652% |
| Precision BioSciences, Inc. | 31.26 Million USD | -181.895% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 52.706% |
| Kura Oncology, Inc. | 17.2 Million USD | -412.459% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -64271.317% |
| TScan Therapeutics, Inc. | 92.43 Million USD | 4.641% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -2969.046% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -530.764% |
| Autolus Therapeutics plc | 52.96 Million USD | -66.411% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -1515.82% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -1511.684% |
| GRI Bio, Inc. | 14 Thousand USD | -629492.857% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -609.458% |
| IGM Biosciences, Inc. | 40.5 Million USD | -117.605% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 50.93% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1392.164% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -10560.173% |
| Opthea Limited | 200.62 Million USD | 56.067% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -51.238% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -52.307% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -675.088% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -1329.732% |
| Surrozen, Inc. | 3.37 Million USD | -2508.553% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -2711.49% |
| Ovid Therapeutics Inc. | 46 Million USD | -91.608% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | 34.468% |
| Acelyrin, Inc. | 1.19 Million USD | -7282.161% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -4.203% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -42069.649% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -191.71% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -41.994% |
| ADMA Biologics, Inc. | 141.41 Million USD | 37.672% |
| PureTech Health plc | 25.51 Million USD | -245.496% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -27617.925% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -4945.392% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -579.277% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -4.097% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -35585.425% |
| ChromaDex Corporation | 3.27 Million USD | -2589.747% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -14070.832% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 53.595% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | 15.395% |
| Better Therapeutics, Inc. | 14.88 Million USD | -492.359% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -187.917% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | 20.54% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -131.322% |
| Seer, Inc. | 28.25 Million USD | -211.911% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -1337.896% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -1296.214% |
| Gritstone bio, Inc. | 104.77 Million USD | 15.874% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -3063.783% |
| Avid Bioservices, Inc. | 207.83 Million USD | 57.59% |
| Insmed Incorporated | 1.2 Billion USD | 92.679% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -1597.016% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -2158.34% |
| Fate Therapeutics, Inc. | 103.53 Million USD | 14.867% |
| MediWound Ltd. | 6.71 Million USD | -1213.411% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | 13.06% |
| Fortress Biotech, Inc. | 88.59 Million USD | 0.507% |
| OmniAb, Inc. | 25.56 Million USD | -244.834% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 58.799% |
| Zai Lab Limited | 15.15 Million USD | -481.764% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 81.577% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -177.773% |
| Veracyte, Inc. | 12.63 Million USD | -597.886% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -1532.278% |
| FibroGen, Inc. | 170.45 Million USD | 48.29% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -4233.483% |
| ContextLogic Inc. | 6 Million USD | -1369.05% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -55686.709% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -1243.848% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 98.479% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -29.185% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -238124.324% |
| ImmuCell Corporation | 11.96 Million USD | -636.409% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 94.747% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1104.633% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -3063.783% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -95.556% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -104.181% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -94.851% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -82.759% |
| Vaxxinity, Inc. | 15.16 Million USD | -481.112% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 89.615% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -8479.246% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -620887.741% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -315.005% |
| Senti Biosciences, Inc. | 37.66 Million USD | -134.012% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -54203.0% |
| Apollomics, Inc. | 4.66 Million USD | -1791.075% |
| 89bio, Inc. | 27.1 Million USD | -225.155% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | 23.468% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -19462.511% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1176.325% |
| Ardelyx, Inc. | 55.98 Million USD | -57.449% |
| Pluri Inc. | 29.61 Million USD | -197.66% |
| Prothena Corporation plc | 11.83 Million USD | -644.766% |
| Pulmatrix, Inc. | 8.75 Million USD | -906.658% |
| Celularity Inc. | 65.41 Million USD | -34.74% |
| MeiraGTx Holdings plc | 89.26 Million USD | 1.256% |
| Omeros Corporation | 338.28 Million USD | 73.944% |
| Ainos, Inc. | 5.96 Million USD | -1378.028% |
| Humacyte, Inc. | 58.1 Million USD | -51.693% |
| Mesoblast Limited | 118.92 Million USD | 25.882% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -4656.773% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -1707.32% |
| Blueprint Medicines Corporation | 774.12 Million USD | 88.614% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -1656.536% |
| Summit Therapeutics Inc. | 106.09 Million USD | 16.924% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -42.585% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | 23.584% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -179.393% |
| Cytokinetics, Incorporated | 755.77 Million USD | 88.337% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -558.57% |
| Nutriband Inc. | 241.28 Thousand USD | -36430.659% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -1512.274% |
| Roivant Sciences Ltd. | 499.74 Million USD | 82.363% |
| Evogene Ltd. | 1.13 Million USD | -7645.431% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -7089.478% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -159680.658% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 94.934% |
| BioLineRx Ltd. | 11.59 Million USD | -660.443% |
| Atai Life Sciences N.V. | 16.47 Million USD | -434.978% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -4057.689% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | 9.696% |
| MediciNova, Inc. | 215.92 Thousand USD | -40720.929% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -3432.786% |
| MiMedx Group, Inc. | 48.09 Million USD | -83.253% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 78.762% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -2355.237% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -5291.009% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -107812.586% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -862.155% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -500.797% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -221.514% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -619.065% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -604.806% |
| Allakos Inc. | 41.46 Million USD | -112.572% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -714.555% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -58272.848% |
| BioAtla, Inc. | 2.46 Million USD | -3483.049% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | 7.336% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -1489.308% |
| Precigen, Inc. | 7.09 Million USD | -1141.975% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | 29.174% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -365.552% |
| Incyte Corporation | 38.28 Million USD | -130.217% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -104.191% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -691.372% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 63.063% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -238.452% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -25155.874% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -26896.903% |
| UroGen Pharma Ltd. | 100.21 Million USD | 12.045% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 51.768% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -25349.7% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -28799.344% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1189.583% |
| Chimerix, Inc. | 2.14 Million USD | -4011.147% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -147.904% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -50946.197% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -232.452% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -187438.298% |
| OncoCyte Corporation | 2.86 Million USD | -2972.255% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -6684.322% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -412747.775% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -58445.771% |
| Purple Biotech Ltd. | 351 Thousand USD | -25011.966% |
| NextCure, Inc. | 6.6 Million USD | -1234.489% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | 9.961% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -1585.012% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 61.542% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -9005.682% |
| NLS Pharmaceutics AG | 1.63 Million USD | -5295.147% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | 68.592% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -3054.724% |
| Daré Bioscience, Inc. | 5.31 Million USD | -1557.401% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -15500.531% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -96.065% |
| BeiGene, Ltd. | 930.18 Million USD | 90.524% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -467.11% |
| Alector, Inc. | 38.91 Million USD | -126.484% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -7625.066% |
| Erasca, Inc. | 55.85 Million USD | -57.796% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -350.698% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -244.901% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -22385.344% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 92.226% |
| Histogen Inc. | 4.62 Million USD | -1807.032% |
| Fortress Biotech, Inc. | 88.59 Million USD | 0.507% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -794.671% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -39.54% |
| Galecto, Inc. | 249 Thousand USD | -35298.795% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 86.332% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 36.601% |
| Molecular Templates, Inc. | 12.23 Million USD | -620.711% |
| PDS Biotechnology Corporation | 23.85 Million USD | -269.547% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -1980.316% |
| Amarin Corporation plc | 8.73 Million USD | -908.847% |
| TG Therapeutics, Inc. | 110.79 Million USD | 20.445% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -1533.185% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -3367.467% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -367.528% |
| Onconetix, Inc. | 9.88 Million USD | -791.615% |
| MacroGenics, Inc. | 33.97 Million USD | -159.465% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -6111.628% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -295.138% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 58.055% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -704.592% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -334.352% |
| SciSparc Ltd. | 76 Thousand USD | -115877.632% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -7.469% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -26691.185% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -248.419% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 57.195% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -64.858% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 96.714% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -1051.083% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -139809.524% |
| 2seventy bio, Inc. | 256.67 Million USD | 65.659% |
| Clene Inc. | 32.16 Million USD | -174.068% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -3915.626% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -43126.211% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -910.698% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -452.378% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -412.549% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -227.901% |
| Entera Bio Ltd. | 390 Thousand USD | -22500.769% |
| Trevena, Inc. | 35.23 Million USD | -150.172% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -249.289% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -220.695% |
| INmune Bio, Inc. | 10.43 Million USD | -744.524% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -18215.619% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -1256.881% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -214882.927% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -226.577% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -17496.82% |
| Jaguar Health, Inc. | 35.86 Million USD | -145.798% |
| Clearside Biomedical, Inc. | 43 Million USD | -104.979% |
| NexImmune, Inc. | 68.8 Thousand USD | -127998.069% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -18855.484% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -7099.896% |
| Kronos Bio, Inc. | 28.27 Million USD | -211.768% |
| Innoviva, Inc. | 449.07 Million USD | 80.372% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 81.669% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 96.739% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -335.941% |
| Verastem, Inc. | 41.55 Million USD | -112.101% |
| ProKidney Corp. | 4.41 Million USD | -1897.349% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -5568.36% |
| Imunon, Inc. | 1.62 Million USD | -5325.139% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -6895.476% |
| Statera Biopharma, Inc. | 16.26 Million USD | -442.047% |
| ImmunityBio, Inc. | 883.67 Million USD | 90.025% |
| Korro Bio, Inc. | 33.2 Million USD | -165.435% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 78.225% |
| Kineta, Inc. | 1.31 Million USD | -6592.711% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -2378.015% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -1470.573% |
| GT Biopharma, Inc. | 58 Thousand USD | -151870.69% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -510.24% |
| Celularity Inc. | 65.41 Million USD | -34.74% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -70.397% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -257.999% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -24.187% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | 20.13% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -22913.838% |
| Kodiak Sciences Inc. | 181.63 Million USD | 51.472% |
| Sana Biotechnology, Inc. | 104.09 Million USD | 15.325% |
| Annexon, Inc. | 31.35 Million USD | -181.113% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -17.468% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -3663.578% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1174.295% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -536.412% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 93.936% |
| Vor Biopharma Inc. | 35.66 Million USD | -147.176% |
| Eyenovia, Inc. | 16.1 Million USD | -447.208% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -21935.75% |
| Puma Biotechnology, Inc. | 111.49 Million USD | 20.941% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -91.453% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -174.435% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -8848.528% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -54.083% |
| Immunocore Holdings plc | 84.03 Million USD | -4.892% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -126.472% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -22.75% |
| Alkermes plc | 290.73 Million USD | 69.682% |
| Arcellx, Inc. | 97.62 Million USD | 9.713% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -3496.211% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -92.565% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -135504.615% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -2741.489% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -6889.773% |
| Moolec Science SA | 2.64 Million USD | -3232.074% |
| Biomea Fusion, Inc. | 10.29 Million USD | -756.09% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -2.612% |
| Mereo BioPharma Group plc | 5.95 Million USD | -1380.897% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -93.678% |
| Royalty Pharma plc | 6.13 Billion USD | 98.563% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -3569.567% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -5190.696% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -76377.172% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -160.547% |
| Humacyte, Inc. | 58.1 Million USD | -51.693% |
| Structure Therapeutics Inc. | 5.45 Million USD | -1516.413% |
| NLS Pharmaceutics AG | 1.63 Million USD | -5295.147% |
| Genelux Corporation | 2.51 Million USD | -3399.127% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -109628.862% |
| aTyr Pharma, Inc. | 15.09 Million USD | -483.922% |
| Notable Labs, Ltd. | 2.04 Million USD | -4201.757% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -29211.239% |
| Mustang Bio, Inc. | 2.49 Million USD | -3428.543% |
| Immunovant, Inc. | 138 Thousand USD | -63771.739% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -5301.829% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 94.121% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -201.612% |
| Orgenesis Inc. | 22.62 Million USD | -289.651% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -1812.411% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -43320.197% |
| GH Research PLC | 343 Thousand USD | -25597.668% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -326.615% |
| PepGen Inc. | 20.1 Million USD | -338.435% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -15255.923% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -87170.297% |
| Belite Bio, Inc | 886 Thousand USD | -9848.42% |
| Pharming Group N.V. | 171.54 Million USD | 48.618% |
| XOMA Corporation | 124.45 Million USD | 29.174% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -8958.89% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 63.215% |
| Xencor, Inc. | 83.43 Million USD | -5.644% |
| Replimune Group, Inc. | 75.86 Million USD | -16.178% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -313.216% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -837.293% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -2642.47% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -423.725% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -3546.794% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -6889.773% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -77902.655% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -8440.988% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -2690.218% |
| scPharmaceuticals Inc. | 40.26 Million USD | -118.885% |
| HilleVax, Inc. | 51.19 Million USD | -72.178% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -64.115% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -870.631% |
| Immunic, Inc. | 1.33 Million USD | -6507.421% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -2521.433% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -21771.712% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -870.631% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -4025.678% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -426.824% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -3999.674% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 80.195% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -30331.6% |
| bluebird bio, Inc. | 330.32 Million USD | 73.316% |
| DBV Technologies S.A. | 14.38 Million USD | -512.913% |
| Compugen Ltd. | 1.35 Million USD | -6424.278% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -722.091% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -3422.902% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -1319.829% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -5124.837% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -106.105% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -1797.997% |
| Benitec Biopharma Inc. | 284 Thousand USD | -30936.268% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -4.243% |
| Adicet Bio, Inc. | 20.92 Million USD | -321.253% |
| Prime Medicine, Inc. | 13.63 Million USD | -546.541% |
| Aditxt, Inc. | 18.21 Million USD | -383.824% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | 24.788% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -475.985% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -10803.362% |
| PolyPid Ltd. | 11.77 Million USD | -648.306% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | 3.625% |
| Invivyd, Inc. | 2.16 Million USD | -3971.27% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -2501311.856% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -45.501% |
| CorMedix Inc. | 667.63 Thousand USD | -13102.333% |
| Instil Bio, Inc. | 86.05 Million USD | -2.428% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -73.948% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 54.375% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -192.581% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -1490.168% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -563.927% |
| AbCellera Biologics Inc. | 77.38 Million USD | -13.909% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -5.701% |
| Surrozen, Inc. | 3.37 Million USD | -2508.553% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -259.152% |
| Verona Pharma plc | 51.32 Million USD | -71.722% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -14517.413% |
| Vir Biotechnology, Inc. | 124.54 Million USD | 29.225% |
| Evaxion Biotech A/S | 10.86 Million USD | -710.907% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -17.67% |
| Shattuck Labs, Inc. | 4.2 Million USD | -1997.644% |
| AlloVir, Inc. | 27.42 Million USD | -221.35% |
| BioVie Inc. | 6.11 Million USD | -1342.261% |
| Codexis, Inc. | 22.36 Million USD | -294.129% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -9628.808% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -53656.549% |
| Agenus Inc. | 350.24 Million USD | 74.834% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -39196.924% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -37492.282% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -318.771% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -353.294% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -135.385% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -4001.582% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -209.415% |
| IN8bio, Inc. | 4.89 Million USD | -1701.41% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -6487.668% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | 16.896% |
| Liquidia Corporation | 3.5 Million USD | -2416.215% |
| Quantum-Si incorporated | 15.3 Million USD | -475.985% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -107812.586% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -708.429% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -5232.305% |
| United Therapeutics Corporation | 700 Million USD | 87.408% |
| Solid Biosciences Inc. | 26.26 Million USD | -235.591% |
| Immuneering Corporation | 4.46 Million USD | -1874.99% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -563.927% |
| uniQure N.V. | 138.4 Million USD | 36.317% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -669.338% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -3.184% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -18456.421% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -563.428% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -41775.347% |
| Cue Biopharma, Inc. | 14.69 Million USD | -499.816% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -32068.978% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -192.474% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -8848.528% |
| Immunome, Inc. | 1.65 Million USD | -5242.0% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -4986.151% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -801.442% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -191.775% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -24248.895% |
| Altimmune, Inc. | 671 Thousand USD | -13036.066% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -70.242% |
| Rallybio Corporation | 392 Thousand USD | -22385.459% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -2008.18% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -14967.179% |
| Moolec Science SA | 2.64 Million USD | -3232.074% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -21139.277% |
| NeurAxis, Inc. | 224.26 Thousand USD | -39203.933% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 85.573% |
| Lumos Pharma, Inc. | 6.58 Million USD | -1238.542% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -801.442% |
| 180 Life Sciences Corp. | 1.32 Million USD | -6577.151% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -342.463% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -416.056% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -5568.36% |
| Nutriband Inc. | 241.28 Thousand USD | -36430.659% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -10571.065% |
| argenx SE | 20 Million USD | -340.715% |
| Neurogene Inc. | 16.25 Million USD | -442.252% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 71.395% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -208.829% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -394.796% |
| Design Therapeutics, Inc. | 3.05 Million USD | -2789.934% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -33542.366% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -519.504% |
| Achilles Therapeutics plc | 4.61 Million USD | -1809.924% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -61972.535% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -763.047% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 76.415% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -192.844% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -2283.618% |
| Palisade Bio, Inc. | 369 Thousand USD | -23786.992% |
| Beam Therapeutics Inc. | 173.17 Million USD | 49.101% |
| AEON Biopharma, Inc. | 278 Thousand USD | -31606.115% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -26211.343% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -82360.637% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -16.189% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -44.244% |
| Athira Pharma, Inc. | 1.58 Million USD | -5461.073% |
| Vaccinex, Inc. | 247 Thousand USD | -35585.425% |
| HCW Biologics Inc. | 6.45 Million USD | -1266.182% |
| XOMA Corporation | 124.45 Million USD | 29.174% |
| Nektar Therapeutics | 230.4 Million USD | 61.744% |
| Arvinas, Inc. | 3.4 Million USD | -2492.441% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -5301.829% |
| Merus N.V. | 12.16 Million USD | -624.741% |
| Omega Therapeutics, Inc. | 128.42 Million USD | 31.368% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -538.07% |
| Rezolute, Inc. | 2.22 Million USD | -3856.149% |
| Clene Inc. | 32.16 Million USD | -174.068% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -50252.179% |
| BeyondSpring Inc. | 3.99 Million USD | -2106.333% |
| Synlogic, Inc. | 17.27 Million USD | -410.234% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -6680.231% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -251737.143% |
| Peak Bio, Inc. | 10.72 Million USD | -722.091% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -69.757% |
| Krystal Biotech, Inc. | 8.09 Million USD | -988.992% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 50.206% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1149.015% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -64429.189% |
| MannKind Corporation | 382.37 Million USD | 76.949% |
| Ikena Oncology, Inc. | 10.73 Million USD | -720.851% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -21450.856% |
| Gossamer Bio, Inc. | 212.46 Million USD | 58.514% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -50556.897% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -862.155% |
| Legend Biotech Corporation | 328.67 Million USD | 73.182% |
| Mural Oncology plc | 15 Million USD | -487.268% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -85.854% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -4095.288% |
| Champions Oncology, Inc. | 7.43 Million USD | -1086.312% |
| REGENXBIO Inc. | 89.29 Million USD | 1.285% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -10212.778% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -15839.579% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -1528.057% |
| Vaxart, Inc. | 26.51 Million USD | -232.439% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -462.949% |
| Cellectis S.A. | 92.85 Million USD | 5.073% |
| Longeveron Inc. | 2.04 Million USD | -4218.618% |
| Repare Therapeutics Inc. | 3.41 Million USD | -2484.839% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 93.69% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -89.181% |
| Revolution Medicines, Inc. | 87.94 Million USD | -0.226% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -50849.711% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -2129.775% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -27705.363% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -50267.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 89.097% |
| Denali Therapeutics Inc. | 52.24 Million USD | -68.724% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -511.872% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -6315.066% |
| Cingulate Inc. | 3.13 Million USD | -2711.49% |
| Passage Bio, Inc. | 26.29 Million USD | -235.221% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -1222.476% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -21503.676% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -9759.396% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -0.226% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -328.69% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -6895.476% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -3496.028% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -2722.382% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -10768.434% |
| OmniAb, Inc. | 25.56 Million USD | -244.834% |
| Anew Medical, Inc. | 1.6 Million USD | -5391.776% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -197.953% |
| Lipocine Inc. | 17.16 Thousand USD | -513374.31% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -657.372% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -154.543% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1392.164% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -54.169% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -43320.197% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -1606.544% |
| Ocugen, Inc. | 6.94 Million USD | -1169.889% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -523.845% |
| Q32 Bio Inc. | 1.31 Million USD | -6587.633% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -13016.518% |
| Alumis Inc. Common Stock | 32.58 Million USD | -170.543% |
| Equillium, Inc. | 824 Thousand USD | -10596.966% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -870.845% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -29202.275% |
| Galera Therapeutics, Inc. | 152.29 Million USD | 42.125% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -72.363% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -11272.586% |
| Dominari Holdings Inc. | 3.02 Million USD | -2810.931% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -93185.849% |
| vTv Therapeutics Inc. | 529 Thousand USD | -16562.193% |
| Bio-Techne Corporation | 419.53 Million USD | 78.99% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -22.428% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 54.464% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -421.927% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -287.238% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -1354.985% |
| Nkarta, Inc. | 88.33 Million USD | 0.222% |
| BioCardia, Inc. | 1.31 Million USD | -6602.89% |
| Iterum Therapeutics plc | 19.5 Million USD | -351.807% |